发明名称 Intermediate of statin drugs and preparation thereof
摘要 The present invention relates to the field of pharmaceutical chemistry, specifically relates to a statin intermediate having formula I and preparation thereof.; The advantages of the method used to prepare the chiral sulfone intermediate having formula I are that a fluorophore is introduced at the beginning of the synthesis, and the intermediates are mostly solid, which enables quality control to be easily carried out.
申请公布号 US9303001(B2) 申请公布日期 2016.04.05
申请号 US201214119448 申请日期 2012.07.19
申请人 SUNSHINE LAKE PHARMA CO., LTD.;YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. 发明人 Zhang Shouhua;Wang Zhongqing;Luo Zhonghua
分类号 C07D257/04;C07D319/06;C07D405/12;C07F7/18;C07B53/00 主分类号 C07D257/04
代理机构 Squire Patton Boggs (US) LLP 代理人 Law Kam W.;Squire Patton Boggs (US) LLP
主权项 1. A method of preparing a chiral sulfone having formula I as a statin intermediate, comprising: (a) reducing a dioxo compound having formula II with a reducing agent to form a dihydroxy compound of formula II-1; (b) protecting the hydroxy groups of the dihydroxy compound of formula II-1 to form a 1,3-dioxane compound of formula II-2; and (c) oxidizing the 1,3-dioxane compound of formula II-2 with an oxidizing agent to form the chiral sulfone, wherein R1 is aryl or heterocyclyl, where the aryl or heterocyclyl is optionally unsubstituted or substituted with one or more substituents, where each of the substituents is independently alkyl, aryl, arylalkyl, halo, cycloalkyl, trifluoromethyl, nitro, cyano, trifluoromethoxy, amido, alkylcarbonyl, thiol or alkylthio; each of R11 and R12 is independently alkyl; and R2 is alkyl, cycloalkyl, arylalkyl, heterocyclyl, aryl or benzyloxycarbonyl.
地址 Dongguan, Guangdong CN